Inflammatory Response to Regulated Cell Death in Gout and Its Functional Implications

Front Immunol. 2022 Apr 6:13:888306. doi: 10.3389/fimmu.2022.888306. eCollection 2022.

Abstract

Gout, a chronic inflammatory arthritis disease, is characterized by hyperuricemia and caused by interactions between genetic, epigenetic, and metabolic factors. Acute gout symptoms are triggered by the inflammatory response to monosodium urate crystals, which is mediated by the innate immune system and immune cells (e.g., macrophages and neutrophils), the NACHT, LRR, and PYD domains-containing protein 3 (NLRP3) inflammasome activation, and pro-inflammatory cytokine (e.g., IL-1β) release. Recent studies have indicated that the multiple programmed cell death pathways involved in the inflammatory response include pyroptosis, NETosis, necroptosis, and apoptosis, which initiate inflammatory reactions. In this review, we explore the correlation and interactions among these factors and their roles in the pathogenesis of gout to provide future research directions and possibilities for identifying potential novel therapeutic targets and enhancing our understanding of gout pathogenesis.

Keywords: NETosis; apoptosis; gout; inflammation; necroptosis; programmed cell death; pyroptosis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arthritis, Gouty* / metabolism
  • Gout* / metabolism
  • Humans
  • Inflammasomes / metabolism
  • Macrophages
  • Pyroptosis

Substances

  • Inflammasomes